Courtesy of Benzinga.
The following are the M&A deals, rumors and chatter circulating on Wall Street for Thursday April 16, 2015:
CollabRx, Medytox to Merge
The Deal:
CollabRx, Inc. (NASDAQ: CLRX) and Medytox Solutions (OTC: MMMS) announced Thursday, that they have entered into a definitive merger agreement. Under the agreement, CollabRx equityholders will own a 10% stake in the combined company and Medytox equityholders will own 90% of the combined company.
CollabRx shares rose 9% Thursday, closing at $1.14.
Macerich’s Fourth Largest Shareholder Wants Plan to Produce as Much Value as Rejected Simon Bid
The Shareholder Comments:
The Macerich Company (NYSE: MAC) shareholder, Cohen & Steers Inc (NASDAQ: CNS) asked Macerich to come up with a plan to deliver the same value as was offered by Simon Property Group Inc (NYSE: SPG), when they offered $95.50 per share. Cohen & Steers’ Executive Chairman Martin Cohen told Reuters on Wednesday, that he favored Simon’s offer, which was rejected by Macerich.
A Macerich spokesman declined to comment on the Cohen comments. Macerich shareholders Land and Buildings and Orange Capital also expressed their dissatisfaction at the rejected Simon offer in a letter to Macerich Chairman and CEO Art Coppola.
Macerich shares gained $0.69 Thursday, closing at $82.99.
Report Says Intel May be Leaning Toward Xilinx
The Rumor:
Shares of Xilinx Inc. (NASDAQ: XLNX) rose Thursday, on a Deal Reporter story that Intel Corporation (NASDAQ: INTC) might be leaning toward an acquisition of Xilinx, versus the previously rumored Altera Corp (NASDAQ: ALTR).
The Wall Street Journal first reported on March 27, that Intel was in talks to acquire Altera. Those talks reportedly ended without an agreement, when Altera rejected a $54.00 per share offer, according to sources.
Xilinx shares gained $0.43 Thursday, closing at $44.33. Alter shares lost $0.07, closing at $43.35.
Posted-In: News Rumors Management Insider Trades M&A Movers